Comparative evaluation of medical RF beauty devices and home-use facial device in continuous use
- Conditions
- Healthy adult Female
- Registration Number
- JPRN-UMIN000053609
- Lead Sponsor
- Japan Clinical Trial Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 16
Not provided
1. Subjects with serious underlying diseases (diabetes, dyslipidemia, cardiovascular disease, osteoporosis, autoimmune disease, etc.) 2. Subjects with chronic skin diseases such as atopic dermatitis 3. Subjects with a history of other serious diseases 4. Currently undergoing hospitalization, medication, or treatment for any disease. 5. Subjects have sensitive skin. 6. Subjects, lactating, or possibly pregnant. 7. Subjects who have undergone immunosuppression or other procedures within the past 3 months. 8. Subjects who have gold threads implanted or are taking or have a history of taking gold preparations (Siozol, Glelease, Rizasto, Ridora, etc.) 9. Subjects who are using a pacemaker or implantable cardioverter defibrillator 10. Subjects who have scars, warts, pimples, art makeup, burns, etc. on the face that may affect the evaluation measurement. 11. Subjects who have any experience of cosmetic or other medical treatment that may affect the subject area (including hyaluronic acid injections, Botox, etc.) 12. Subjects who have more than 5 metallic objects (bolts, silver teeth, etc.) in the treatment of the upper jaw. 13. Subjects who are undergoing dental treatment (braces, implants, etc.) 14. Subjects who may have allergic reactions to test product ingredients. 15. Claustrophobia 16. Subjects who have a smoking habit. 17. Subjects who have difficulty in maintaining their lifestyle (diet, exercise, sleep, skin care, etc.) 18. Subjects who drink excessively (e.g., more than 500 ml of beer, 1 cup (180 ml) of sake, 2 glasses (200 ml) of wine)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method